138 related articles for article (PubMed ID: 32861171)
1. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells.
Bazavar M; Fazli J; Valizadeh A; Ma B; Mohammadi E; Asemi Z; Alemi F; Maleki M; Xing S; Yousefi B
Pathol Res Pract; 2020 Nov; 216(11):153176. PubMed ID: 32861171
[TBL] [Abstract][Full Text] [Related]
2. miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma.
Xu W; Li Z; Zhu X; Xu R; Xu Y
Med Sci Monit; 2018 Dec; 24():8812-8821. PubMed ID: 30518744
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
Han Z; Shi L
Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS.
Li X; Liu Y; Zhang X; Shen J; Xu R; Liu Y; Yu X
Aging (Albany NY); 2020 Jul; 12(14):14157-14173. PubMed ID: 32706759
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.
Zhou Y; Zhao RH; Tseng KF; Li KP; Lu ZG; Liu Y; Han K; Gan ZH; Lin SC; Hu HY; Min DL
Acta Pharmacol Sin; 2016 Apr; 37(4):519-29. PubMed ID: 26924291
[TBL] [Abstract][Full Text] [Related]
6. LncRNA EBLN3P attributes methotrexate resistance in osteosarcoma cells through miR-200a-3p/O-GlcNAc transferase pathway.
Sun MX; An HY; Sun YB; Sun YB; Bai B
J Orthop Surg Res; 2022 Dec; 17(1):557. PubMed ID: 36544170
[TBL] [Abstract][Full Text] [Related]
7. MiR-505 mediates methotrexate resistance in colorectal cancer by targeting RASSF8.
Chen Y; Bian L; Zhang Y
J Pharm Pharmacol; 2018 Jul; 70(7):937-951. PubMed ID: 29726011
[TBL] [Abstract][Full Text] [Related]
8. MiR-595 Suppresses the Cellular Uptake and Cytotoxic Effects of Methotrexate by Targeting SLC19A1 in CEM/C1 Cells.
Wang SM; Sun LL; Wu WS; Yan D
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):8-13. PubMed ID: 29345051
[TBL] [Abstract][Full Text] [Related]
9. S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells.
Ding L; Wang C; Cui Y; Han X; Zhou Y; Bai J; Li R
Int J Oncol; 2018 Jun; 52(6):1841-1852. PubMed ID: 29620168
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma.
Scionti I; Michelacci F; Pasello M; Hattinger CM; Alberghini M; Manara MC; Bacci G; Ferrari S; Scotlandi K; Picci P; Serra M
Ann Oncol; 2008 Aug; 19(8):1500-1508. PubMed ID: 18385200
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504
[TBL] [Abstract][Full Text] [Related]
14. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
[TBL] [Abstract][Full Text] [Related]
16. Quercetin and Methotrexate in Combination have Anticancer Activity in Osteosarcoma Cells and Repress Oncogenic MicroRNA-223.
Mohammadi E; Alemi F; Maleki M; Malakoti F; Farsad-Akhtar N; Yousefi B
Drug Res (Stuttg); 2022 Apr; 72(4):226-233. PubMed ID: 35385884
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.
Song B; Wang Y; Xi Y; Kudo K; Bruheim S; Botchkina GI; Gavin E; Wan Y; Formentini A; Kornmann M; Fodstad O; Ju J
Oncogene; 2009 Nov; 28(46):4065-74. PubMed ID: 19734943
[TBL] [Abstract][Full Text] [Related]
18. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
[TBL] [Abstract][Full Text] [Related]
19. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
Yan H; Zhang B; Fang C; Chen L
Anticancer Drugs; 2018 Jun; 29(5):440-448. PubMed ID: 29494357
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-related receptor alpha confers methotrexate resistance via attenuation of reactive oxygen species production and P53 mediated apoptosis in osteosarcoma cells.
Chen P; Wang H; Duan Z; Zou JX; Chen H; He W; Wang J
Biomed Res Int; 2014; 2014():616025. PubMed ID: 24967384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
